Recursion Pharmaceuticals dropped its share prices by 6.45 percent on Monday to close at $4.93 apiece as investors appeared to have booked profits following four straight days of gains. In recent ...

A predictive biophysical model that integrates protein-DNA structures and sequences to accurately determine genomic binding sites and affinities of DNA-binding proteins.

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Find the latest institutional holdings data for Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) including shareholders, ownership summaries, and holding activities at Nasdaq.com.

Learn about and revise how to continue sequences and find the nth term of linear and quadratic sequences with GCSE Bitesize Edexcel Maths.

View the most recent data and latest information on option chains for Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) at Nasdaq.com.